Cargando…
COVID-19 and gut immunomodulation
The disease coronavirus disease 2019 (COVID-19) is a severe respiratory illness that has emerged as a devastating health problem worldwide. The disease outcome is heterogeneous, and severity is likely dependent on the immunity of infected individuals and comorbidities. Although symptoms of the disea...
Autores principales: | Roy, Koushik, Agarwal, Sidra, Banerjee, Rajib, Paul, Manash K, Purbey, Prabhat K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678818/ https://www.ncbi.nlm.nih.gov/pubmed/35046621 http://dx.doi.org/10.3748/wjg.v27.i46.7925 |
Ejemplares similares
-
Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2
por: Purbey, Prabhat K., et al.
Publicado: (2023) -
Parasite immunomodulation and polymorphisms of the immune system
por: Maizels, Rick M
Publicado: (2009) -
Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma
por: Russo, Edda, et al.
Publicado: (2022) -
Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
por: Sen, Saikat, et al.
Publicado: (2021) -
Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations
por: da Costa, Adriano Carneiro, et al.
Publicado: (2020)